Pharmacological Treatment of Patients With Chronic Critical Limb Ischemia: L-propionyl-carnitine Enhances the Short-Term Effects of PGE-1
This randomized controlled trial investigated the effects of L-propionyl-carnitine (LPC) combined with prostaglandin E1 (PGE-1) on patients with chronic critical limb ischemia (CLI). The study showed that LPC enhanced the short-term effects of PGE-1, suggesting potential therapeutic benefits for CLI patients. However, the study did not provide detailed statistical results
June 26, 2025
No Comments